Agency Forms Undergoing Paperwork Reduction Act Review, 19974-19975 [2016-07806]
Download as PDF
<![CDATA[
19974
Federal Register / Vol. 81, No. 66 / Wednesday, April 6, 2016 / Notices
necessary for the proper performance of
the FDIC’s functions, including whether
the information has practical utility; (b)
The accuracy of the estimates of the
burden of the collections of information,
including the validity of the
methodology and assumptions used; (c)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) Ways to minimize the
burden of the collections of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. All comments will become
a matter of public record.
Dated at Washington, DC, this 31st day of
March 2016.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2016–07819 Filed 4–5–16; 8:45 am]
BILLING CODE 6714–01–P
FEDERAL MARITIME COMMISSION
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Notice of Agreements Filed
The Commission hereby gives notice
of the filing of the following agreements
under the Shipping Act of 1984.
Interested parties may submit comments
on the agreements to the Secretary,
Federal Maritime Commission,
Washington, DC 20573, within twelve
days of the date this notice appears in
the Federal Register. Copies of the
agreements are available through the
Commission’s Web site (www.fmc.gov)
or by contacting the Office of
Agreements at (202)–523–5793 or
tradeanalysis@fmc.gov.
Agreement No.: 010071–044.
Title: Cruise Lines International
Association Agreement.
Parties: Acromas Shipping, Ltd./Saga
Shipping; Aida Cruises; AMA
Waterways; American Cruise Lines, Inc.;
Aqua Expeditions Pte. Ltd.; Australian
Pacific Touring Pty Ltd.; Avalon
Waterways; Azamara Cruises; Carnival
Cruise Lines; CDF Croisieres de France;
Celebrity Cruises, Inc.; Celestyal
Cruises; Costa Cruise Lines; Compagnie
Du Ponant; Croisieurope; Cruise &
Maritime Voyages; Crystal Cruises;
Cunard Line; Disney Cruise Line;
Emerald Waterways; Evergreen Tours;
Fred.Olsen Cruise Lines Ltd.; HapagLloyd Kreuzfahrten Gmbh; Hebridean
Island Cruises; Holland America Line;
Hurtigruten, Inc.; Island Cruises;
Lindblad Expeditions Pty Ltd.; Luftner
Cruises; Mekong Waterways; MSC
Cruises; NCL Corporation; Oceania
Cruises; P & O Cruises; P & O Cruises
Australia; Paul Gauguin Cruises; Pearl
VerDate Sep<11>2014
17:54 Apr 05, 2016
Jkt 238001
Seas Cruises; Phoenix Reisen Gmbh;
Princess Cruises; Pullmantur Cruises
Ship Management Ltd.; Regent Seven
Seas Cruises; Riviera Tours Ltd.; Royal
Caribbean International; Scenic Tours
UK Ltd.; Seabourn Cruise Line;
SeaDream Yacht Club; Shearings
Holidays Ltd.; Silversea Cruises, Ltd.;
Star Cruises (HK) Limited; St. Helena
Line/Andrew Weir Shipping Ltd.; Swan
Hellenic; Tauck River Cruising; The
River Cruise Line; Thomson Cruises;
Travelmarvel; Tui Cruises Gmbh; UnCruises Adventures; Uniworld River
Cruises, Inc.; Venice Simplon-OrientExpress Ltd./Belmond; Voyages of
Discovery; Voyages to Antiquity (UK)
Ltd.; and Windstar Cruises.
Filing Party: Andre Picciurro, Esq.
Kaye, Rose & Partners, LLP; Emerald
Plaza, 402 West Broadway, Suite 1300;
San Diego, CA 92101–3542
Synopsis: The amendment would add
language to clarify that the agreement
can represent its members before federal
and state judiciaries.
Agreement No.: 011223–052.
Title: Transpacific Stabilization
Agreement.
Parties: American President Lines,
Ltd. and APL Co. PTE Ltd.; (operating
as a single carrier); Maersk Line A/S;
CMA CGM, S.A.; COSCO Container
Lines Company Ltd; Evergreen Line
Joint Service Agreement; Hanjin
Shipping Co., Ltd.; Hapag-Lloyd AG;
Hyundai Merchant Marine Co., Ltd.;
Kawasaki Kisen Kaisha Ltd.; MSC
Mediterranean Shipping Company S.A.;
Nippon Yusen Kaisha; Orient Overseas
Container Line Limited; Yangming
Marine Transport Corp.; and Zim
Integrated Shipping Services, Ltd.
Filing Party: David F. Smith, Esq.;
Cozen O’Conner; 1200 Nineteenth Street
NW.; Washington, DC 20036.
Synopsis: The amendment deletes
China Shipping Container Lines (Hong
Kong) Company Limited and China
Shipping Container Lines Company
Limited as parties to the agreement.
Agreement No.: 012288–002.
Title: Hoegh/NYK Atlantic/Pacific
Space Charter Agreement.
Parties: Hoegh Autoliners AS and
Nippon Yusen Kaisha.
Filing Party: Wayne Rohde, Esq.;
Cozen O’Connor; 1200 Nineteenth St.
NW.; Washington, DC 20006.
Synopsis: The amendment adds the
trades between the U.S. West Coast, on
the one hand, and Thailand, Taiwan,
Indonesia, Malaysia, Brunei,
Philippines, Bangladesh, Vietnam, Sri
Lanka, Myanmar, Singapore, Australia
and New Zealand on the other hand, to
the geographic scope of the agreement.
By Order of the Federal Maritime
Commission.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Dated: April 1, 2016.
Karen V. Gregory,
Secretary.
[FR Doc. 2016–07890 Filed 4–5–16; 8:45 am]
BILLING CODE 6731–AA–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-16–0469]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
E:\FR\FM\06APN1.SGM
06APN1
19975
Federal Register / Vol. 81, No. 66 / Wednesday, April 6, 2016 / Notices
Proposed Project
National Program of Cancer Registries
Cancer Surveillance System (NPCR CSS,
OMB No. 0920–0469, exp. 5/31/2016)—
Revision—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In 2012, the most recent year for
which complete information is
available, more than 580,000 people
died of cancer and more than 1.5
million were diagnosed with cancer. It
is estimated that 13.8 million Americans
are currently alive with a history of
cancer (2). In the U.S., state-based
cancer registries are the only method for
systematically collecting and reporting
population based information about
cancer incidence and outcomes such as
survival. These data are used to measure
the changing incidence and burden of
each cancer; identify populations at
increased or increasing risk; target
preventive measures; and measure the
success or failure of cancer control
efforts in the U.S.
In 1992, Congress passed the Cancer
Registries Amendment Act which
established the National Program of
Cancer Registries (NPCR). The NPCR
provides support for state-based cancer
registries that collect, manage and
analyze data about cancer cases. The
state-based cancer registries report
information to CDC through the
National Program of Cancer Registries
Cancer Surveillance System (NPCR
CSS), (OMB No. 0920–0469 5/31/2016).
CDC plans to request OMB approval to
continue collecting this information for
three years. Data definitions will be
updated to reflect changes in national
standards for cancer diagnosis and
coding, but the number of respondents
and the burden per respondent will not
change.
The NPCR CSS allows CDC to collect,
aggregate, evaluate and disseminate
cancer incidence data at the national
level. The NPCR CSS is the primary
source of information for United States
Cancer Statistics (USCS), which CDC
has published annually since 2002. The
latest USCS report published in 2015
provided cancer statistics for 99% of the
United States population from all cancer
registries whose data met national data
standards. Prior to the publication of
USCS, cancer incidence data at the
national level were available for only
14% of the population of the United
States.
The NPCR CSS also allows CDC to
monitor cancer trends over time,
describe geographic variation in cancer
incidence throughout the country, and
provide incidence data on racial/ethnic
populations and rare cancers. These
activities and analyses further support
CDC’s planning and evaluation efforts
for state and national cancer control and
prevention. In addition, datasets can be
made available for secondary analysis.
Respondents are NPCR-supported
central cancer registries (CCR) in 45 U.S.
states, 2 territories, and the District of
Columbia. Thirty-eight CCR submit data
elements specified for the Standard
NPCR CSS Report. Ten specialized CCR
submit data elements specified for the
Enhanced NPCR CSS Report, which
includes additional information about
treatment and follow-up for cases of
breast, colorectal, and chronic myeloid
leukemia cases diagnosed in 2011. Each
CCR is asked to transmit two data files
to CDC per year. The first file, submitted
in January, is a preliminary report
consisting of one year of data for the
most recent year of available data. CDC
evaluates the preliminary data for
completeness and quality and provides
a report back to the CCR. The second
file, submitted by November, contains
cumulative cancer incidence data from
the first diagnosis year for which the
cancer registry collected data with the
assistance of NPCR funds (e.g., 1995)
through 12 months past the close of the
most recent diagnosis year (e.g., 2014).
The cumulative file is used for analysis
and reporting. The burden for each file
transmission is estimated at two hours
per response. Because cancer incidence
data are already collected and
aggregated at the state level the
additional burden of reporting the
information to CDC is small.
All information is transmitted to CDC
electronically. Participation is required
as a condition of the cooperative
agreement with CDC. There are no costs
to respondents except their time.
The total estimated annualized
burden hours are 192 (152 for the
Standard NPCR CSS Report, and 40 for
the Enhanced NPCR CSS Report).
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Number of
respondents
Form name
Central Cancer Registries in States, Territories and the District of Columbia.
Number of
responses
per
respondent
Average
burden per
response
(in hours)
asabaliauskas on DSK3SPTVN1PROD with NOTICES
[FR Doc. 2016–07806 Filed 4–5–16; 8:45 am]
BILLING CODE 4163–18–P
38
2
2
Enhanced NPCR CSS Report
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
Standard NPCR CSS Report
10
2
2
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2016–N–0001]
Endocrinologic and Metabolic Drugs
Advisory Committee; Amendment of
Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
SUMMARY:
VerDate Sep<11>2014
17:54 Apr 05, 2016
Jkt 238001
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
amendment to the notice of a meeting of
the Endocrinologic and Metabolic Drugs
Advisory Committee. This meeting was
announced in the Federal Register of
March 16, 2016. The amendment is
being made to reflect a change in the
Date and Time portion of the document.
The Date of the meeting is changed to
May 25, 2016. There are no other
changes.
FOR FURTHER INFORMATION CONTACT:
LaToya Bonner, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417,
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 81, Number 66 (Wednesday, April 6, 2016)]
[Notices]
[Pages 19974-19975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07806]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0469]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
[[Page 19975]]
Proposed Project
National Program of Cancer Registries Cancer Surveillance System
(NPCR CSS, OMB No. 0920-0469, exp. 5/31/2016)--Revision--National
Center for Chronic Disease Prevention and Health Promotion (NCCDPHP),
Centers for Disease Control and Prevention (CDC).
Background and Brief Description
In 2012, the most recent year for which complete information is
available, more than 580,000 people died of cancer and more than 1.5
million were diagnosed with cancer. It is estimated that 13.8 million
Americans are currently alive with a history of cancer (2). In the
U.S., state-based cancer registries are the only method for
systematically collecting and reporting population based information
about cancer incidence and outcomes such as survival. These data are
used to measure the changing incidence and burden of each cancer;
identify populations at increased or increasing risk; target preventive
measures; and measure the success or failure of cancer control efforts
in the U.S.
In 1992, Congress passed the Cancer Registries Amendment Act which
established the National Program of Cancer Registries (NPCR). The NPCR
provides support for state-based cancer registries that collect, manage
and analyze data about cancer cases. The state-based cancer registries
report information to CDC through the National Program of Cancer
Registries Cancer Surveillance System (NPCR CSS), (OMB No. 0920-0469 5/
31/2016). CDC plans to request OMB approval to continue collecting this
information for three years. Data definitions will be updated to
reflect changes in national standards for cancer diagnosis and coding,
but the number of respondents and the burden per respondent will not
change.
The NPCR CSS allows CDC to collect, aggregate, evaluate and
disseminate cancer incidence data at the national level. The NPCR CSS
is the primary source of information for United States Cancer
Statistics (USCS), which CDC has published annually since 2002. The
latest USCS report published in 2015 provided cancer statistics for 99%
of the United States population from all cancer registries whose data
met national data standards. Prior to the publication of USCS, cancer
incidence data at the national level were available for only 14% of the
population of the United States.
The NPCR CSS also allows CDC to monitor cancer trends over time,
describe geographic variation in cancer incidence throughout the
country, and provide incidence data on racial/ethnic populations and
rare cancers. These activities and analyses further support CDC's
planning and evaluation efforts for state and national cancer control
and prevention. In addition, datasets can be made available for
secondary analysis.
Respondents are NPCR-supported central cancer registries (CCR) in
45 U.S. states, 2 territories, and the District of Columbia. Thirty-
eight CCR submit data elements specified for the Standard NPCR CSS
Report. Ten specialized CCR submit data elements specified for the
Enhanced NPCR CSS Report, which includes additional information about
treatment and follow-up for cases of breast, colorectal, and chronic
myeloid leukemia cases diagnosed in 2011. Each CCR is asked to transmit
two data files to CDC per year. The first file, submitted in January,
is a preliminary report consisting of one year of data for the most
recent year of available data. CDC evaluates the preliminary data for
completeness and quality and provides a report back to the CCR. The
second file, submitted by November, contains cumulative cancer
incidence data from the first diagnosis year for which the cancer
registry collected data with the assistance of NPCR funds (e.g., 1995)
through 12 months past the close of the most recent diagnosis year
(e.g., 2014). The cumulative file is used for analysis and reporting.
The burden for each file transmission is estimated at two hours per
response. Because cancer incidence data are already collected and
aggregated at the state level the additional burden of reporting the
information to CDC is small.
All information is transmitted to CDC electronically. Participation
is required as a condition of the cooperative agreement with CDC. There
are no costs to respondents except their time.
The total estimated annualized burden hours are 192 (152 for the
Standard NPCR CSS Report, and 40 for the Enhanced NPCR CSS Report).
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Central Cancer Registries in States, Standard NPCR CSS Report 38 2 2
Territories and the District of
Columbia.
Enhanced NPCR CSS Report 10 2 2
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07806 Filed 4-5-16; 8:45 am]
BILLING CODE 4163-18-P
